Literature DB >> 21924518

False-positive urine phencyclidine immunoassay screen result caused by interference by tramadol and its metabolites.

Binh T Ly1, Stephen L Thornton, Colleen Buono, Judith A Stone, Alan H B Wu.   

Abstract

Phencyclidine is one of the drugs of abuse included in qualitative urine drug screens that are frequently ordered in the emergency department despite concerns about specificity and clinical utility. Many drugs have been described to cause false-positive results for phencyclidine. We present 2 cases of false-positive phencyclidine qualitative urine drug screen results in patients with seizures from tramadol misuse or abuse. The involvement of tramadol and its active metabolite, N-desmethyltramadol, was confirmed by in vitro testing. These cases illustrate that tramadol and its metabolites can trigger a false-positive phencyclidine urine drug screen result in nonfatal cases and highlight the lack of specificity of the phencyclidine qualitative urine drug screen.
Copyright © 2011 American College of Emergency Physicians. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21924518     DOI: 10.1016/j.annemergmed.2011.08.013

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  3 in total

1.  Buyer Beware: Pitfalls in Toxicology Laboratory Testing.

Authors:  D Adam Algren; Michael R Christian
Journal:  Mo Med       Date:  2015 May-Jun

2.  How often do false-positive phencyclidine urine screens occur with use of common medications?

Authors:  Arvind Rengarajan; Michael E Mullins
Journal:  Clin Toxicol (Phila)       Date:  2013-05-23       Impact factor: 4.467

3.  Effects of naloxone and diazepam on blood glucose levels in tramadol overdose using generalized estimating equation (GEE) model; (an experimental study).

Authors:  Samaneh Nakhaee; Khadijeh Farrokhfall; Ebrahim Miri-Moghaddam; Masoumeh Askari; Alireza Amirabadizadeh; Mohsen Foadoddini; Omid Mehrpour
Journal:  BMC Endocr Disord       Date:  2021-09-06       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.